Can the Helicobacter pylori eradication regimen induce platelet recovery in H. pylori-negative patients with idiopathic thrombocytopenic purpura?
Hiroto Ohguchi
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorJunichi Kameoka
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorHideo Harigae
Department of Molecular Diagnostics, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorMinami Yamada
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorYasuo Tomiya
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorShinichiro Takahashi
Department of Molecular Diagnostics, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorKenichi Ishizawa
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorNozomu Sano
Department of Gastroenterology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorHitoshi Sekine
Department of Gastroenterology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorTakeshi Sasaki
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorHiroto Ohguchi
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorJunichi Kameoka
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorHideo Harigae
Department of Molecular Diagnostics, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorMinami Yamada
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorYasuo Tomiya
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorShinichiro Takahashi
Department of Molecular Diagnostics, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorKenichi Ishizawa
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorNozomu Sano
Department of Gastroenterology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorHitoshi Sekine
Department of Gastroenterology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this authorTakeshi Sasaki
Department of Rheumatology and Hematology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Search for more papers by this author
REFERENCES
- 1Emilia G, Longo G, Luppi M, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001; 97: 812–814.
- 2Ando K, Shimamoto T, Tauchi T, et al. Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenia purpura? Our experience and a literature review. Int J Hematol 2003; 77: 239–244.
- 3Hino M, Yamane T, Park K, et al. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 2003; 82: 30–32.
- 4Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004; 103: 890–896.
- 5Takahashi T,YujiriT,Tanizawa Y. Helicobacter pylori and chronic ITP: the discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains. Blood 2004; 104: 594.
Citing Literature
